{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:48:28Z","timestamp":1781214508936,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2648,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1038\/jid.2008.59","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T11:59:26Z","timestamp":1206619166000},"page":"2204-2210","source":"Crossref","is-referenced-by-count":22,"title":["Topical CpG Enhances the Response of Murine Malignant Melanoma to Dacarbazine"],"prefix":"10.1016","volume":"128","author":[{"given":"Hossain M.","family":"Najar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Dutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2008.59_bb0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1038\/jid.2008.59_bb0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1084\/jem.185.3.453","article-title":"Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma","volume":"185","author":"Bloom","year":"1997","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2008.59_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0039-6109(02)00187-1","article-title":"Medical management of melanoma","volume":"83","author":"Brown","year":"2003","journal-title":"Surg Clin North Am"},{"key":"10.1038\/jid.2008.59_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nm1352","article-title":"Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity","volume":"12","author":"Chan","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/jid.2008.59_bb0030","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.4049\/jimmunol.170.8.4102","article-title":"A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells","volume":"170","author":"Datta","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.59_bb0035","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1158\/0008-5472.CAN-06-0206","article-title":"Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine","volume":"66","author":"den Brok","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2008.59_bb0040","first-page":"517","article-title":"Dacarbazine","volume":"128","author":"D\u2019Incan","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1038\/jid.2008.59_bb0045","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrc1167","article-title":"Adoptive-cell-transfer therapy for the treatment of patients with cancer","volume":"3","author":"Dudley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/jid.2008.59_bb0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2006.07664.x","article-title":"Phase I\/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma","volume":"156","author":"Green","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2008.59_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.immunol.19.1.47","article-title":"Cross-presentation, dendritic cells, tolerance and immunity","volume":"19","author":"Heath","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/jid.2008.59_bb0060","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1038\/jid.2008.59_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6109(02)00162-7","article-title":"Immunotherapy of malignant melanoma","volume":"83","author":"Kadison","year":"2003","journal-title":"Surg Clin North Am"},{"key":"10.1038\/jid.2008.59_bb0070","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI31414","article-title":"Development of TLR9 agonists for cancer therapy","volume":"117","author":"Krieg","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2008.59_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/jid.2008.59_bb0080","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.171.8.4320","article-title":"Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses","volume":"171","author":"Lore","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.59_bb0085","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.200636212","article-title":"Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do","volume":"37","author":"Najar","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1038\/jid.2008.59_bb0090","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.170.10.4905","article-title":"Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8T cells","volume":"170","author":"Nowak","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.59_bb0095","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20021031","article-title":"Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus","volume":"196","author":"O\u2019Keeffe","year":"2002","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2008.59_bb0100","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4049\/jimmunol.173.5.3051","article-title":"Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod","volume":"173","author":"Palamara","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.59_bb0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF01215928","article-title":"Mechanisms of hepatotoxicity caused by dacarbazine in rats","volume":"119","author":"Paschke","year":"1993","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1038\/jid.2008.59_bb0110","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1200\/JCO.2006.07.9129","article-title":"Phase II trial of a Toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma","volume":"24","author":"Pashenkov","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2008.59_bb0115","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.jid.5700777","article-title":"Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions","volume":"127","author":"Redondo","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.59_bb0120","series-title":"Cochrane Database Syst Rev","article-title":"Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma","author":"Sasse","year":"2007"},{"key":"10.1038\/jid.2008.59_bb0125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20012100","article-title":"Rapid induction of tumor-specific type 1T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells","volume":"195","author":"Schuler-Thurner","year":"2002","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2008.59_bb0130","first-page":"1095","article-title":"Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells","volume":"61","author":"Seliger","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2008.59_bb0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00262-004-0516-x","article-title":"CpG-oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response","volume":"53","author":"Sfondrini","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/jid.2008.59_bb0140","first-page":"830","article-title":"Treatment of locally metastatic melanoma: a novel approach","volume":"6","author":"Shistik","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1038\/jid.2008.59_bb0145","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","article-title":"Apoptosis and melanoma chemoresistance","volume":"22","author":"Soengas","year":"2003","journal-title":"Oncogene"},{"key":"10.1038\/jid.2008.59_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1356","article-title":"A novel dendritic cell subset involved in tumor immunosurveillance","volume":"12","author":"Taieb","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/jid.2008.59_bb0155","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1523-1747.2003.12252.x","article-title":"Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model","volume":"120","author":"Thallinger","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.59_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008390-200106000-00006","article-title":"Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model","volume":"11","author":"Wack","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1038\/jid.2008.59_bb0165","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1535-7163.MCT-06-0094","article-title":"Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9","volume":"5","author":"Wang","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/jid.2008.59_bb0170","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)","volume":"23","author":"Weeratna","year":"2005","journal-title":"Vaccine"},{"key":"10.1038\/jid.2008.59_bb0175","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20052433","article-title":"Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime\u2013boost immunization in nonhuman primates","volume":"203","author":"Wille-Reece","year":"2006","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15340082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15340082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T15:58:31Z","timestamp":1557417511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15340082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0022202X15340082"],"URL":"https:\/\/doi.org\/10.1038\/jid.2008.59","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}